Bronchodilator
Pregnancy: C — theophylline levels altered in pregnancy; monitor closely
Aminophylline
Brand names: Phyllocontin
Adult dose
Dose: Loading: 5mg/kg IV over 20–30 min. Infusion: 500mcg/kg/h
Route: IV (slow infusion)
Frequency: Loading dose then continuous infusion
Max: 1g loading (max); infusion rate titrated to levels
Loading dose ONLY if NOT already on theophylline. If on oral theophylline: do NOT give loading dose (risk of toxicity). Monitor levels: target 10–20 mg/L. Reduce infusion rate in HF, cirrhosis, elderly, and severe COPD.
Dose adjustments
Renal
No adjustment required — hepatically metabolised.
Hepatic
Reduce infusion rate by 50% in hepatic impairment.
Clinical pearls
- Aminophylline = theophylline + ethylenediamine (80% theophylline). Levels reported as theophylline equivalents.
- Narrow therapeutic index: therapeutic 10–20 mg/L; toxic >20 mg/L. Measure level 6h after starting infusion.
- MAGICS trial: IV magnesium sulphate now preferred over aminophylline in severe acute asthma — fewer adverse effects, similar efficacy.
- Role limited in modern practice: use only for life-threatening asthma unresponsive to maximal first-line therapy.
Contraindications
- Porphyria
- Already on oral theophylline (do not give loading dose)
- Hypersensitivity to theophylline or ethylenediamine
Side effects
- Nausea, vomiting, GI discomfort (at levels >15 mg/L)
- Tachycardia, palpitations, arrhythmias
- Headache, insomnia
- Seizures (at toxic levels >30 mg/L)
- Hypokalaemia (potentiates salbutamol)
Interactions
- Ciprofloxacin / erythromycin: markedly increase theophylline levels — halve aminophylline dose or avoid
- Rifampicin / phenytoin: reduce theophylline levels
- Cimetidine: increases theophylline levels
- Salbutamol: additive hypokalaemia — monitor K+
Monitoring
- Theophylline level (trough and at 6h)
- HR (ECG)
- K+
- BP
Reference: BTS/SIGN Asthma 2023; NICE BNF 84. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024